» Articles » PMID: 8026474

Functional Interaction Between the HCMV IE2 Transactivator and the Retinoblastoma Protein

Overview
Journal EMBO J
Date 1994 Jun 15
PMID 8026474
Citations 92
Authors
Affiliations
Soon will be listed here.
Abstract

The 86 kDa immediate early IE2 protein of human cytomegalovirus (HCMV) can activate transcription of both viral and cellular genes and can repress transcription from its own promoter. Using two in vivo assays, we provide evidence of a functional interaction between IE2 and the retinoblastoma (RB) protein: IE2 alleviates RB-induced repression of a promoter bearing E2F binding sites and RB alleviates IE2-mediated repression of its own promoter. These functional effects are likely to be a result of a direct contact between IE2 and RB, which we can demonstrate both in vitro and in HCMV-infected cells. The interaction between IE2 and RB shows similar characteristics to the interaction between RB and E1A. First, binding to IE2 requires an intact RB pocket domain. Secondly, the binding is sensitive to the phosphorylation state of RB, because cyclin A-CDK-induced phosphorylation of RB diminishes IE2 binding. Thirdly, the IE2 domain required for RB binding is separate to the domains necessary for TBP and TFIIB binding. Our results demonstrate that large and small DNA viruses have a common interface with the host cell, namely the association with the RB tumour suppressor protein.

Citing Articles

HPV and HCMV in Cervical Cancer: A Review of Their Co-Occurrence in Premalignant and Malignant Lesions.

Blanco R, Munoz J Viruses. 2024; 16(11).

PMID: 39599814 PMC: 11599080. DOI: 10.3390/v16111699.


DNA damage response(DDR): a link between cellular senescence and human cytomegalovirus.

Wu X, Zhou X, Wang S, Mao G Virol J. 2023; 20(1):250.

PMID: 37915066 PMC: 10621139. DOI: 10.1186/s12985-023-02203-y.


The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme.

Daei Sorkhabi A, Sarkesh A, Saeedi H, Marofi F, Ghaebi M, Silvestris N Front Oncol. 2022; 12:818447.

PMID: 35515137 PMC: 9062077. DOI: 10.3389/fonc.2022.818447.


Emerging Mechanisms of G/S Cell Cycle Control by Human and Mouse Cytomegaloviruses.

Bogdanow B, Phan Q, Wiebusch L mBio. 2021; 12(6):e0293421.

PMID: 34903047 PMC: 8669474. DOI: 10.1128/mBio.02934-21.


Valganciclovir as Add-On to Standard Therapy in Secondary Glioblastoma.

Stragliotto G, Pantalone M, Rahbar A, Soderberg-Naucler C Microorganisms. 2020; 8(10).

PMID: 32987955 PMC: 7599902. DOI: 10.3390/microorganisms8101471.


References
1.
St Jeor S, Hutt R . Cell DNA replication as a function in the synthesis of human cytomegalovirus. J Gen Virol. 1977; 37(1):65-73. DOI: 10.1099/0022-1317-37-1-65. View

2.
Rustgi A, Dyson N, Bernards R . Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product. Nature. 1991; 352(6335):541-4. DOI: 10.1038/352541a0. View

3.
Malone C, Vesole D, Stinski M . Transactivation of a human cytomegalovirus early promoter by gene products from the immediate-early gene IE2 and augmentation by IE1: mutational analysis of the viral proteins. J Virol. 1990; 64(4):1498-506. PMC: 249283. DOI: 10.1128/JVI.64.4.1498-1506.1990. View

4.
Caswell R, Hagemeier C, Chiou C, Hayward G, Kouzarides T, Sinclair J . The human cytomegalovirus 86K immediate early (IE) 2 protein requires the basic region of the TATA-box binding protein (TBP) for binding, and interacts with TBP and transcription factor TFIIB via regions of IE2 required for transcriptional regulation. J Gen Virol. 1993; 74 ( Pt 12):2691-8. DOI: 10.1099/0022-1317-74-12-2691. View

5.
Helin K, Lees J, Vidal M, Dyson N, Harlow E, Fattaey A . A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell. 1992; 70(2):337-50. DOI: 10.1016/0092-8674(92)90107-n. View